DE60115938D1 - Monoklonale antikörper gegen hepatitis b virus - Google Patents

Monoklonale antikörper gegen hepatitis b virus

Info

Publication number
DE60115938D1
DE60115938D1 DE60115938T DE60115938T DE60115938D1 DE 60115938 D1 DE60115938 D1 DE 60115938D1 DE 60115938 T DE60115938 T DE 60115938T DE 60115938 T DE60115938 T DE 60115938T DE 60115938 D1 DE60115938 D1 DE 60115938D1
Authority
DE
Germany
Prior art keywords
hepatitis
virus
hbsag antigen
monoclonal antibodies
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115938T
Other languages
English (en)
Other versions
DE60115938T2 (de
Inventor
Mylene Lesenechal
Nicole Battail-Poirot
Laurence Becquart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of DE60115938D1 publication Critical patent/DE60115938D1/de
Application granted granted Critical
Publication of DE60115938T2 publication Critical patent/DE60115938T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60115938T 2000-10-20 2001-10-12 Monoklonale antikörper gegen hepatitis b virus Expired - Lifetime DE60115938T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0013454 2000-10-20
FR0013454A FR2815634B1 (fr) 2000-10-20 2000-10-20 Anticorps monoclonaux diriges contre des virus de l'hepatite b
PCT/FR2001/003169 WO2002034789A1 (fr) 2000-10-20 2001-10-12 Anticorps monoclonaux diriges contre des virus de l'hepatite b

Publications (2)

Publication Number Publication Date
DE60115938D1 true DE60115938D1 (de) 2006-01-19
DE60115938T2 DE60115938T2 (de) 2006-07-27

Family

ID=8855552

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115938T Expired - Lifetime DE60115938T2 (de) 2000-10-20 2001-10-12 Monoklonale antikörper gegen hepatitis b virus

Country Status (9)

Country Link
US (1) US7785586B2 (de)
EP (1) EP1326895B8 (de)
JP (1) JP4293788B2 (de)
AT (1) ATE312846T1 (de)
AU (1) AU2001295700A1 (de)
DE (1) DE60115938T2 (de)
ES (1) ES2252301T3 (de)
FR (1) FR2815634B1 (de)
WO (1) WO2002034789A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
KR101262732B1 (ko) * 2004-06-07 2013-05-09 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 Ｂ 형 간염 표면 항원에 대한 토끼 모노클로날 항체 및이것의 사용 방법
CA2594922A1 (en) * 2005-01-14 2006-07-20 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Monoclonal antibodies that bind or neutralize hepatitis b virus
JP4948783B2 (ja) * 2005-05-18 2012-06-06 シスメックス株式会社 抗ＨＢｓモノクローナル抗体
EP2858674B1 (de) 2012-07-10 2019-01-30 Green Cross Corporation Antikörperzusammensetzung zur prävention oder behandlung von mutanten hepatitis-b-virusinfektionen
KR101646830B1 (ko) * 2013-05-31 2016-08-08 (주)셀트리온 Ｂ형 간염 바이러스를 중화시킬 수 있는 결합 분자
US9714284B2 (en) * 2013-07-16 2017-07-25 National Health Research Institutes Antibodies and method for determining deletions in HBV pre-S2 region
CN104845938B (zh) * 2015-04-17 2018-07-03 北京科兴中维生物技术有限公司 乙型肝炎病毒表面抗原单克隆抗体及其应用
CN111234013B (zh) * 2018-11-29 2022-01-11 清华大学 乙肝病毒的中和抗体b430及其应用
WO2023143445A1 (zh) * 2022-01-25 2023-08-03 厦门大学 用于治疗hbv感染及相关疾病的表位肽及抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204095A (en) * 1980-04-09 1993-04-20 National Research Development Corporation Monoclonal antibodies against hepatitis B virus
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine
US6030616A (en) * 1993-03-24 2000-02-29 Imperial College Of Science, Technology & Medicine Hepatitis B escape mutant specific binding molecules
GB9325772D0 (en) * 1993-12-16 1994-02-16 Smithkline Beecham Biolog Novel compounds
GB9608626D0 (en) * 1996-04-25 1996-07-03 Univ College Of London Hepatitis b monoclonal antibodies
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization

Also Published As

Publication number Publication date
EP1326895B8 (de) 2006-06-21
JP4293788B2 (ja) 2009-07-08
FR2815634A1 (fr) 2002-04-26
AU2001295700A1 (en) 2002-05-06
DE60115938T2 (de) 2006-07-27
US20040219154A1 (en) 2004-11-04
ATE312846T1 (de) 2005-12-15
EP1326895A1 (de) 2003-07-16
US7785586B2 (en) 2010-08-31
ES2252301T3 (es) 2006-05-16
WO2002034789A1 (fr) 2002-05-02
FR2815634B1 (fr) 2003-10-31
EP1326895B1 (de) 2005-12-14
JP2004516824A (ja) 2004-06-10

Similar Documents

Publication Publication Date Title
DE69111801D1 (de) Vakzin gegen hepatitis b.
DK1135498T3 (da) Antistofvarianter med höjere bindingsaffinitet end forældreantistoffer
JP2002533123A5 (de)
FI941199A0 (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
ATE414106T1 (de) Pegylierte single-domain-antikörper (dab)
EA200100619A1 (ru) Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов
FI935808A0 (fi) Hepatit-C-virus (HCV) polypeptider
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
HUP0303134A3 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
UY28641A1 (es) Anticuerpos
DE60234085D1 (de) Rekombinantes super-verbindungs-interferon zur verwendung als hepatitis b oberflächenatigen und e-antigen-inhibitor
DE60115938D1 (de) Monoklonale antikörper gegen hepatitis b virus
MX9603182A (es) Vacuna de hepatitis b.
NO20051715L (no) HCV assay
DE69224134D1 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
DE69922834D1 (de) Humanisierter antikörper spezifisch für das oberflächenantigen pre-s1 von hbv und dessen präparation
DK1002092T3 (da) Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf
IS6143A (is) Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni
ATE552264T1 (de) Neue oberflächenprotein- (hbsag-) variante des hepatitis b virus
BRPI0204599B8 (pt) kit para a detecção simultânea de anticorpo para hcv e antígeno de hcv
DE69814884D1 (de) Hepatitis b virale polypeptide
GR3036125T3 (en) Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines.
FR2818648B1 (fr) Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih

Legal Events

Date Code Title Description
8364 No opposition during term of opposition